GRAHAM HUGHES: Open Payments
NPI 1639632557 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,876 in 192 payments from 19 companies in 2025. Trend: 2023 $771 · 2024 $2,532 · 2025 $2,876
Food & beverage: $2,876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $517 |
| Otsuka America Pharmaceutical, Inc. | 28 | $371 |
| Axsome Therapeutics, Inc. | 16 | $369 |
| Neos Therapeutics, LP | 13 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $201 |
| E.R. Squibb & Sons, L.L.C. | 13 | $173 |
| Vanda Pharmaceuticals Inc. | 13 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $156 |
| Lundbeck LLC | 8 | $151 |
| Corium, LLC | 6 | $120 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, Adzenys XR-ODT, COBENFY, TRINTELLIX, HETLIOZ.
Industry payments across OH — which companies pay providers there.
